Epigenetic effects of the continuous exposure to peroxisome proliferator WY-14,643 in mouse liver are dependent upon peroxisome proliferator activated receptor α

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 625, Issue 1-2, 2007, Pages 62-71

  Pogribny, Igor P ^a   Tryndyak, Volodymyr P ^a   Woods, Courtney G ^b   Witt, Sarah E ^a   Rusyn, Ivan ^b  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b University of North Carolina at Chapel Hill   (United States)

Author keywords

Cancer; DNA methylation; Epigenetics; Liver; Peroxisome proliferators

Indexed keywords

HISTONE H3; HISTONE H4; MYC PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PIRINIXIC ACID;

ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; EPIGENETICS; LIVER CARCINOGENESIS; LIVER TUMOR; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BASE SEQUENCE; CARCINOGENS; CPG ISLANDS; DNA METHYLATION; DNA PRIMERS; EPIGENESIS, GENETIC; HISTONES; LIVER; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; MICE; MICE, KNOCKOUT; PEROXISOME PROLIFERATORS; PPAR ALPHA; PYRIMIDINES; RETROELEMENTS; TERMINAL REPEAT SEQUENCES;

MAMMALIA; MUS; RODENTIA;

EID: 35548936857     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2007.05.004     Document Type: Article

References (49)

1. Jaffe L.F. Epigenetic theories of cancer initiation. Adv. Cancer Res. 90 (2003) 209-230
2. Feinberg A.P., Ohlsson R., and Henikoff S. The epigenetic progenitor origin of human cancer. Nat. Rev. Genet. 7 (2006) 21-33
3. Shuker D.E. The enemy at the gates? DNA adducts as biomarkers of exposure to exogenous and endogenous genotoxic agents. Toxicol. Lett. 134 (2002) 51-56
4. Silva L.B., and Van der Laan J.W. Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard. Regul. Toxicol. Pharmacol. 32 (2000) 135-143
5. Peraza M.A., Burdick A.D., Marin H.E., Gonzalez F.J., and Peters J.M. The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR). Toxicol. Sci. 90 (2006) 269-295
6. Reddy J.K., Rao M.S., Azarnoff D.L., and Sell S. Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14, 643), in rat and mouse liver. Cancer Res. 39 (1979) 152-161
7. Rusyn I., Peters J.M., and Cunningham M.L. Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver. Crit. Rev. Toxicol. 36 (2006) 459-479
8. Klaunig J.E., Babich M.A., Baetcke K.P., Cook J.C., Corton J.C., David R.M., Deluca J.G., Lai D.Y., McKee R.H., Peters J.M., Roberts R.A., and Fenner-Crisp P.A. PPARalpha agonist-induced rodent tumors: modes of action and human relevance. Crit. Rev. Toxicol. 33 (2003) 655-780
9. Peters J.M., Cattley R.C., and Gonzalez F.J. Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. Carcinogenesis 18 (1997) 2029-2033
10. Peters J.M., Cheung C., and Gonzalez F.J. Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand?. J. Mol. Med. 83 (2005) 774-785
11. Ge R., Wang W., Kramer P.M., Yang S., Tao L., and Pereira M.A. Wy-14,643-induced hypomethylation of the c-myc gene in mouse liver. Toxicol. Sci. 62 (2001) 28-35
12. Tao L., Wang W., Li L., Kramer P.K., and Pereira M.A. DNA hypomethylation induced by drinking water disinfection by-products in mouse and rat kidney. Toxicol. Sci. 87 (2005) 344-352
13. Bachman A.N., Phillips J.M., and Goodman J.I. Phenobarbital induces progressive patterns of GC-rich and gene-specific altered DNA methylation in the liver of tumor-prone B6C3F1 mice. Toxicol. Sci. 91 (2006) 393-405
14. Pogribny I.P., Ross S.A., Wise C., Pogribna M., Jones E.A., Tryndyak V.P., James S.J., Dragan Y.P., and Poirier L.A. Irreversible global DNA hypomethylation as a key step in hepatocarcinogenesis induced by dietary methyl deficiency. Mutat. Res. 593 (2006) 80-87
15. Pogribny I.P., Tryndyak V.P., Muskhelishvili L., Rusyn I., and Ross S.A. Methyl deficiency, alterations in global histone modifications, and carcinogenesis. J. Nutr. 137 (2007) 216S-222S
16. Yamada Y., Jackson-Grusby L., Linhart H., Meissner A., Eden A., Lin H., and Jaenisch R. Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 13580-13585
17. Goodman J.I., and Watson R.E. Altered DNA methylation: a secondary mechanism involved in carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 42 (2002) 501-525
18. Lee S.S., Pineau T., Drago J., Lee E.J., Owens J.W., Kroetz D.L., Fernandez-Salguero P.M., Westphal H., and Gonzalez F.J. Targeted disruption of the alpha isoform of the peroxisome proliferator- activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell Biol. 15 (1995) 3012-3022
19. Pogribny I., Yi P., and James S.J. A sensitive new method for rapid detection of abnormal methylation patterns in global DNA and within CpG islands. Biochem. Biophys. Res. Commun. 262 (1999) 624-628
20. Gonzalgo M.L., Liang G., Spruck III C.H., Zingg J.M., Rideout III W.M., and Jones P.A. Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res. 57 (1997) 594-599
21. Watson R.E., Curtin G.M., Doolittle D.J., and Goodman J.I. Progressive alterations in global and GC-rich DNA methylation during tumorigenesis. Toxicol. Sci. 75 (2003) 289-299
22. Tryndyak V., Kovalchuk O., and Pogribny I.P. Identification of differentially methylated sites within unmethylated DNA domains in normal and cancer cells. Anal. Biochem. 356 (2006) 202-207
23. Martens J.H., O'Sullivan R.J., Braunschweig U., Opravil S., Radolf M., Steinlein P., and Jenuwein T. The profile of repeat-associated histone lysine methylation states in the mouse epigenome. EMBO J. 24 (2005) 800-812
24. Xiong Z., and Laird P.W. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res. 25 (1997) 2532-2534
25. Tryndyak V.P., Muskhelishvili L., Kovalchuk O., Rodriguez-Juarez R., Montgomery B., Churchwell M.I., Ross S.A., Beland F.A., and Pogribny I.P. Effect of long-term tamoxifen exposure on genotoxic and epigenetic changes in rat liver: implications for tamoxifen-induced hepatocarcinogenesis. Carcinogenesis 27 (2006) 1713-1720
26. C.G. Woods, A.M. Burns, B.U. Bradford, P.K. Ross, O. Kosyk, J.A. Swenberg, M.L. Cunningham, I. Rusyn. WY-14,643-induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase, Toxicol. Sci. In Press.
27. Rollins R.A., Haghighi F., Edwards J.R., Das R., Zhang M.Q., Ju J., and Bestor T.H. Large-scale structure of genomic methylation patterns. Genome Res. 16 (2006) 157-163
28. Schulz W.A., Steinhoff C., and Florl A.R. Methylation of endogenous human retroelements in health and disease. Curr. Top. Microbiol. Immunol. 310 (2006) 211-250
29. Santos-Rosa H., and Caldas C. Chromatin modifier enzymes, the histone code and cancer. Eur. J. Cancer 41 (2005) 2381-2402
30. Kourmouli N., Jeppesen P., Mahadevhaiah S., Burgoyne P., Wu R., Gilbert D.M., Bongiorni S., Prantera G., Fanti L., Pimpinelli S., Shi W., Fundele R., and Singh P.B. Heterochromatin and tri-methylated lysine 20 of histone H4 in animals. J. Cell Sci. 117 (2004) 2491-2501
31. Xie W., Radominska-Pandya A., Shi Y., Simon C.M., Nelson M.C., Ong E.S., Waxman D.J., and Evans R.M. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc. Natl. Acad Sci U. S. A. 98 (2001) 3375-3380
32. Ehrlich M. Cancer-linked DNA hypomethylation and its relationship to hypermethylation. Curr. Top. Microbiol. Immunol. 310 (2006) 251-274
33. Liang G., Chan M.F., Tomigahara Y., Tsai Y.C., Gonzales F.A., Li E., Laird P.W., and Jones P.A. Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements. Mol. Cell Biol. 22 (2002) 480-491
34. Rusyn I., Rose M.L., Bojes H.K., and Thurman R.G. Novel role of oxidants in the molecular mechanism of action of peroxisome proliferators. Antioxid. Redox Signal. 2 (2000) 607-621
35. O'Brien M.L., Spear B.T., and Glauert H.P. Role of oxidative stress in peroxisome proliferator-mediated carcinogenesis. Crit. Rev. Toxicol. 35 (2005) 61-88
36. Valinluck V., Tsai H.H., Rogstad D.K., Burdzy A., Bird A., and Sowers L.C. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res. 32 (2004) 4100-4108
37. Cerda S., and Weitzman S.A. Influence of oxygen radical injury on DNA methylation. Mutat. Res. 386 (1997) 141-152
38. Valinluck V., and Sowers L.C. Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res. 67 (2007) 946-950
39. Rusyn I., Denissenko M.F., Wong V.A., Butterworth B.E., Cunningham M.L., Upton P.B., Thurman R.G., and Swenberg J.A. Expression of base excision repair enzymes in rat and mouse liver is induced by peroxisome proliferators and is dependent upon carcinogenic potency. Carcinogenesis 21 (2000) 2141-2145
40. Peters A.H., O'Carroll D., Scherthan H., Mechtler K., Sauer S., Schofer C., Weipoltshammer K., Pagani M., Lachner M., Kohlmaier A., Opravil S., Doyle M., Sibilia M., and Jenuwein T. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107 (2001) 323-337
41. Chalitchagorn K., Shuangshoti S., Hourpai N., Kongruttanachok N., Tangkijvanich P., Thong-ngam D., Voravud N., Sriuranpong V., and Mutirangura A. Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 23 (2004) 8841-8846
42. Saito Y., Kanai Y., Sakamoto M., Saito H., Ishii H., and Hirohashi S. Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis. Proc. Natl. Acad Sci U. S. A. 99 (2002) 10060-10065
43. K. Asada, Y. Kotake, R. Asada, D. Saunders, R.H. Broyles, R.A. Towner, H. Fukui, R.A. Floyd. LINE-1 Hypomethylation in a Choline-Deficiency-Induced Liver Cancer in Rats: Dependence on Feeding Period, J Biomed Biotechnol. 2006 (2006) 17142-.
44. Tryndyak V.P., Kovalchuk O., Muskhelishvili L., Montgomery B., Rodriguez-Juarez R., Melnyk S., Ross S.A., Beland F.A., and Pogribny I.P. Epigenetic reprogramming of liver cells in tamoxifen-induced rat hepatocarcinogenesis. Mol. Carcinog. 46 (2007) 187-197
45. Fraga M.F., Ballestar E., Villar-Garea A., Boix-Chornet M., Espada J., Schotta G., Bonaldi T., Haydon C., Ropero S., Petrie K., Iyer N.G., Perez-Rosado A., Calvo E., Lopez J.A., Cano A., Calasanz M.J., Colomer D., Piris M.A., Ahn N., Imhof A., Caldas C., Jenuwein T., and Esteller M. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat. Genet. 37 (2005) 391-400
46. Sanders S.L., Portoso M., Mata J., Bahler J., Allshire R.C., and Kouzarides T. Methylation of histone H4 lysine 20 controls recruitment of Crb2 to sites of DNA damage. Cell 119 (2004) 603-614
47. Ait-Si-Ali S., Guasconi V., Fritsch L., Yahi H., Sekhri R., Naguibneva I., Robin P., Cabon F., Polesskaya A., and Harel-Bellan A. A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells. EMBO J. 23 (2004) 605-615
48. Kazazian Jr. H.H. Mobile elements: drivers of genome evolution. Science 303 (2004) 1626-1632
49. Coleman W.B., and Tsongalis G.J. Molecular mechanisms of human carcinogenesis. EXS (2006) 321-349